DailyHum Logo
2 No-Brainer Buys for 2022
Nov 28, 2021 | The Motley Fool
Picture - 2 No-Brainer Buys for 2022

There are two things that look to be near certainties for 2022: COVID-19 will still be problematic for countries around the world, and interest rates will rise. And two stocks that are safe bets to do well because of that are Pfizer (NYSE:PFE) and JPMorgan Chase (NYSE:JPM).

Both of their businesses have been performing well this year and could potentially do even better in 2022. Here's why.

This past year has been an exceptionally strong one for Pfizer. The healthcare giant has been banking on strong growth due to its COVID-19 vaccine, which it projects will bring in a whopping $36 billion in revenue for 2021. That's significant when you consider that in 2020, the company's total revenue was $41.9 billion. And with COVID-19 unfortunately not disappearing soon, there's more growth on the horizon. Next year, the company estimates sales from the vaccine will bring in $29 billion.

Sponsored
2 hours ago | Entrepreneur
3 Sales & Earnings Growth Winners
12 of the best places to propose in Italy
4 hours ago | A Luxury Travel Blog
Travel
Win a luxury short stay in Santorini!
6 hours ago | A Luxury Travel Blog
Travel